Latest news with #AERB


The Hindu
06-07-2025
- Business
- The Hindu
Atomic energy board grants operational licence to two home-built 700 MWe reactors in Gujarat
India's nuclear regulator, the Atomic Energy Regulatory Board (AERB), has granted operation licence for two indigenously developed 700 MWe Pressurised Heavy Water Reactors at the Kakrapar Atomic Power Station (KAPS) in Gujarat. The KAPS-3 reactor was commissioned at full power in August 2023, while the KAPS-4 unit followed the same month a year later. "The AERB has concluded the design and commissioning safety reviews and issued the Licence for Operation of Units 3 and 4 of KAPS, the country's first 700 MWe indigenous Pressurized Heavy Water Reactors [PHWRs]," a statement from the regulator said. Since the 700 MWe reactor was the first of its kind, the licensing process involved rigorous multi-tiered safety reviews and assessment of the reactor design, covering the entire life cycle in multiple stages from siting, construction to commissioning at full-power. The Nuclear Power Corporation of India Limited (NPCIL) received the Licence for Operation for KAPS 3&4 from the AERB for a period of five years on July 3. The issuance of the licence is a shot in the arm for the NPCIL, which is spearheading building 10 PHWRs of 700 MWe each in fleet mode. India has 15 PHWRs of 220 MWe and two of 540 MWe capacity operational at various sites across the country. The 540 MWe PHWR design was upgraded to 700 MWe and the first pair of such reactors are operational at Kakrapar. A similar 700 MWe reactor at Rawatbhata in Rajasthan began commercial operations in March this year. Besides the AERB, several reactor safety experts from the technical support organisations made significant contributions towards review of the design and commissioning results, which spanned almost 15 years. As a part of Phase-C commissioning, KAPS-3 received permission for full power operation in August 2023, followed by KAPS-4 in August 2024. After further review of plant performance close to rated power, the AERB has now granted the License for Operation to the NPCIL for five years.


Hindustan Times
06-07-2025
- Business
- Hindustan Times
AERB grants operational license to two home-built 700 MW PHWRS in Gujarat
New Delhi, India's nuclear regulator AERB has granted operation license for two indigenously developed 700 MW Pressurised Heavy Water Reactors at the Kakrapar Atomic Power Station in Gujarat. AERB grants operational license to two home-built 700 MW PHWRS in Gujarat The KS-3 reactor was commissioned at full power in August 2023, while the KS-4 unit followed the same month a year later. "The Atomic Energy Regulatory Board has concluded the Design and Commissioning Safety Reviews and issued the License for Operation of Units 3 and 4 of KS-3&4, the country's first 700 MWe indigenous Pressurized Heavy Water Reactors ," a statement from the regulator said. Since the 700 MW reactor was the first of its kind, the licensing process involved rigorous multi-tiered safety reviews and assessment of the reactor design, covering the entire life cycle in multiple stages from siting, construction to commissioning at full-power. The Nuclear Power Corporation of India Limited received the License for Operation for KS 3&4 from the AERB for a period of five years on July 3. The issuance of the license is a shot in the arm for NPCIL, which is spearheading building 10 PHWRs of 700 MWe each in fleet mode. India has 15 PHWRs of 220 MWe and two of 540 MWe capacity operational at various sites across the country. The 540 MWe PHWR design was upgraded to 700 MWe and the first pair of such reactors are operational at Kakrapar. A similar 700 MW reactor at Rawatbhata in Rajasthan began commercial operations in March this year. Besides AERB, several reactor safety experts from the Technical Support Organisations made significant contributions towards review of the Design and Commissioning results, which spanned almost 15 years. As a part of Phase-C Commissioning, KS-3 received permission for full power operation in August 2023, followed by KS-4 in August 2024. After further review of plant performance close to rated power, AERB has now granted the License for Operation to NPCIL for a period of five years. This article was generated from an automated news agency feed without modifications to text.
&w=3840&q=100)

Business Standard
06-07-2025
- Business
- Business Standard
AERB grants operational license to two home-built 700 MW PHWRS in Gujarat
India's nuclear regulator AERB has granted operation license for two indigenously developed 700 MW Pressurised Heavy Water Reactors at the Kakrapar Atomic Power Station (KAPS) in Gujarat. The KAPS-3 reactor was commissioned at full power in August 2023, while the KAPS-4 unit followed the same month a year later. "The Atomic Energy Regulatory Board (AERB) has concluded the Design and Commissioning Safety Reviews and issued the License for Operation of Units 3 and 4 of KAPS-3&4, the country's first 700 MWe indigenous Pressurized Heavy Water Reactors (PHWRs)," a statement from the regulator said. Since the 700 MW reactor was the first of its kind, the licensing process involved rigorous multi-tiered safety reviews and assessment of the reactor design, covering the entire life cycle in multiple stages from siting, construction to commissioning at full-power. The Nuclear Power Corporation of India Limited (NPCIL) received the License for Operation for KAPS 3&4 from the AERB for a period of five years on July 3. The issuance of the license is a shot in the arm for NPCIL, which is spearheading building 10 PHWRs of 700 MWe each in fleet mode. India has 15 PHWRs of 220 MWe and two of 540 MWe capacity operational at various sites across the country. The 540 MWe PHWR design was upgraded to 700 MWe and the first pair of such reactors are operational at Kakrapar. A similar 700 MW reactor at Rawatbhata in Rajasthan began commercial operations in March this year. Besides AERB, several reactor safety experts from the Technical Support Organisations made significant contributions towards review of the Design and Commissioning results, which spanned almost 15 years. As a part of Phase-C Commissioning, KAPS-3 received permission for full power operation in August 2023, followed by KAPS-4 in August 2024. After further review of plant performance close to rated power, AERB has now granted the License for Operation to NPCIL for a period of five years.


Hindustan Times
28-06-2025
- Health
- Hindustan Times
Teen beats cancer after ‘ultra-high' dose nuclear therapy at Mumbai's TMC
In a pathbreaking medical feat, a 17-year-old boy suffering from relapsed Neuroblastoma, an aggressive form of paediatric cancer, was given a new lease of life through an experimental nuclear therapy conducted at ACTREC (Advanced Centre for Treatment, Research and Education in Cancer), R&D wing of the Tata Memorial Centre in Navi Mumbai. The boy, who was first diagnosed in 2022 at age 14, had undergone a stem cell transplant but suffered a relapse earlier this year, leaving doctors with limited options.(Unsplash/Representational) Doctors at the facility administered an ultra-high dose of radioactive 131-Iodine MIBG therapy, 800 millicurie, nearly three times the permissible limit set by the Atomic Energy Regulatory Board (AERB), making it the highest dosage ever used in India for treating Neuroblastoma. The procedure, conducted on May 5, was the result of a meticulously planned, three-month-long collaborative effort by six departments at ACTREC, with guidance from Memorial Sloan Kettering Cancer Center in the US. 'This form of cancer is almost never diagnosed early. Most cases, by the time they come to us, are already in stage four,' said Dr Venkatesh Rangarajan, head of nuclear medicine at Tata Memorial Hospital. The boy, who was first diagnosed in 2022 at age 14, had undergone a stem cell transplant but suffered a relapse earlier this year, leaving doctors with limited options. That's when the medical team proposed 131-I MIBG—a form of targeted nuclear medicine therapy. While Indian protocols have previously capped radioactive dosage at 300 millicurie, this particular case warranted a drastic step forward. 'Administering 800 millicurie required exceptional safety measures and a special nod from the AERB,' said Dr Rangarajan. 'The major challenge was to shield healthcare staff and others from gamma radiation, which meant constructing an isolated high-safety ward and ensuring no one except the core team was exposed.' Also read: He stole to fund his son's cancer treatment, was still behind bars when boy died One of the most dangerous side effects of such high-dose radioisotope therapy is bone marrow suppression. To mitigate this, doctors harvested and stored the patient's bone marrow before treatment. It was reinfused into his body after the therapy concluded. Another unusual condition for the therapy: the patient had to remain in complete isolation for five days. Today, the boy is back home, cancer-free, and dreaming of becoming a doctor himself. 'His resilience and the team's extraordinary commitment made this success possible,' said Dr Gupta.


India.com
31-05-2025
- Business
- India.com
India to build nuclear power plants in this state bordering Pakistan, government approves...
India to build nuclear power plants in this state bordering Pakistan, government approves… What comes as good news for Rajasthan, a state bordering Pakistan, is that a major nuclear project is going to start in the state. The mega project also got the green light from India's nuclear regulator to build four 700 MW capacity units of nuclear power reactors in Mahi Banswara. AERB Approved The Project After three levels of review, the Atomic Energy Regulatory Board (AERB) has approved the project site. These indigenously developed reactors will play a crucial role in meeting the country's energy needs. After approving the project, the AERB stated that the consent will be reviewed again if the conditions are not followed. The Mahi Banswara project is being implemented by Anushakti Vidyut Nigam. It is a joint venture of NPCIL and National Thermal Power Corporation (NTPC). These Companies To Build Nuclear Power Plants India's Nuclear Power Corporation of India Limited (NPCIL) and Bharatiya Nabhikiya Vidyut Nigam Limited (Bhavini) currently hold the authority to construct and manage nuclear power plants. A 2015 amendment to the Atomic Energy Act of 1962 enabled joint ventures between NPCIL and other public sector entities for this purpose. Meanwhile, ongoing genomic surveillance is monitoring for new COVID-19 variants. Current cases are reported as mild, and the public is advised to remain vigilant but not alarmed. It is worth noting that India is the world's fastest-growing economy and it requires a significant amount of electricity. To meet the electricity needs of high economic growth and the requirement of 1.3 billion people, the country needs to make and take action on big plans, on which work is also being done rapidly. Coal Is The Major Source Of Energy India primarily generates electricity from coal but is actively expanding its renewable energy sector, encompassing solar, wind, hydro, and biomass power. Nuclear power generation is also being developed. India's nuclear power generation capacity has significantly expanded over the past decade, nearly doubling from 4,780 MW in 2014 to 8,180 MW in 2024. Further growth is projected, with a threefold increase to 22,480 MW anticipated by 2031-32. Thorium Reserve Notably, India has an abundant reserve of thorium, which amounts to 21 percent of the global thorium. To make better use of the resource, indigenous projects such as Bhavani are being developed so that the dependency on importing uranium and other materials can be reduced. Currently, as many as nine atomic power projects are under construction, while several others are in the pipeline will start in the coming years.